2008Heilongjiang Medical JournalRequires access

Clinical Study on Hypertension Nephropathy with Telmisartan

Ping Kang

Open publisher page 0 citations

Abstract

Objective To study the curative effect on hypertension nephropathy treated with telmisartan.Methods 40 cases of such patient were divided into two groups randomly.The therapy group was treated with telmisartan and control group was treated with valsartan.The changes of Bp,urine protein,BUN,creatinine,blood routine test as liver and kidney function,electrolyte,lipid and ECG were observed before and after treatment.The t test was analyzed.Results The Bp was decreased in both group and more obviously in therapy group with significant difference P0.05.The urine protein,BUN and creatinine in therapy grup were decreased obviously after treatment with P0.05.Conclusion The telmisartan might decrease blood pressure and urine protein to protect renal function and delay the progress of hypertension.

About this research paper

What this paper is about

Objective To study the curative effect on hypertension nephropathy treated with telmisartan.Methods 40 cases of such patient were divided into two groups randomly.The therapy group was treated with telmisartan and control group was treated with valsartan.The changes of Bp,urine protein,BUN,creatinine,blood routine test as liver and kidney function,electrolyte,lipid and ECG were observed before and after treatment.The t test was analyzed.Results The Bp was decreased in both group and more obviously in therapy group with significant difference P0.05.The urine protein,BUN and creatinine in therapy grup were decreased obviously after treatment with P0.05.Conclusion The telmisartan might decrease blood pressure and urine protein to protect renal function and delay the progress of hypertension.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the curative effect on hypertension nephropathy treated with telmisartan.Methods 40 cases of such patient were divided into two groups randomly.The therapy group was treated with telmisartan and control group was treated with valsartan.The changes of Bp,urine protein,BUN,creatinine,blood routine test as liver and kidney function,electrolyte,lipid and ECG were observed before and after treatment.The t test was analyzed.Results The Bp was decreased in both group and more obviously in therapy group with significant difference P0.05.The urine protein,BUN and creatinine in therapy grup were decreased obviously after treatment with P0.05.Conclusion The telmisartan might decrease blood pressure and urine protein to protect renal function and delay the progress of hypertension.

Key concepts: Telmisartan, Medicine, Valsartan, Renal function, Creatinine, Urology, Blood pressure, Nephropathy

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Study on Hypertension Nephropathy with Telmisartan — Research Paper | ScholarLens